Fundz
Back to Investors

Track Janus Henderson Investors's Investment Activity

Get real-time alerts when Janus Henderson Investors makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $49/mo
J

Janus Henderson Investors

Venture Capital
www.janushenderson.com

What they invest in

Based on the funding rounds Janus Henderson Investors joined in the last 2 years.

31
Deals in the last 2 years
3
Deals in the last 90 days
28
Companies backed
$115M
Typical round size they join (most between $67.5M and $205M)
37%
Rounds they led (10 of 27 where the lead was named)
Stages
Series C and later40%(10)
Series B28%(7)
Series A20%(5)
Other (loans, buyouts, grants, IPOs)12%(3)
Top industries
Where the companies are
United States86%(24)
United Kingdom7%(2)
Switzerland4%(1)
Thailand4%(1)
Deals per quarter
3
2
3
5
9
6
3
Q4 '24Q1 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Who they invest alongside

Firms that joined the same rounds as Janus Henderson Investors in the last 2 years

R
Ra Capital Management

Most recently together in Korsana Biosciences (Post-IPO Equity, $380M)

12
deals together
I
7
deals together
O
7
deals together
186 more firms with ProSee plans
Total Deals
43
Recent (90d)
4
Total Capital
$5.9B
Co-Investors
218
Reached by introduction

No public route for founders. The site is built for people buying their funds (individual investors, advisers, institutions), and the only contact channels are client-service phone lines and an investor contact form.

Worth knowing. This is a listed asset manager selling mutual funds and ETFs, not a venture firm: nowhere on the site is there a team, page or form for a company seeking capital, so there is nothing to apply to and any approach has to go through whoever already knows the portfolio manager.

Raising right now?

See every fund writing checks into companies like yours, ranked, each with a route in.

Build my investor list
I

Immix Biopharma

BiotechnologyLos Angeles, United States
post-ipo equity
$125.0M

Sep 29, 2026

K

Korsana Biosciences

BiotechnologyWaltham, United States
post-ipo equity
$380.0M

Sep 8, 2026

E

Epicrispr Biotechnologies

BiotechnologySouth San Francisco, United States
series c
$176.8M

Aug 10, 2026

D

Draig Therapeutics

BiotechnologyCardiff, United Kingdom
series b
$65.0M

Jul 14, 2026

L

Lycia Therapeutics, Inc.

BiotechnologySan Francisco, United States
series d
$75.0M

Jun 25, 2026

38+ more investments

View all 43 deals by Janus Henderson Investors

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity and website modifications, based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 281,000+ organizations (233,000 operating companies, 48,000 investment funds), ~78,000 with live signal activity and 40,000+ investors.

Fundz tracks 45,000 investors and their 13F holdings, alongside every round the companies they back raise.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.